Colossal Biosciences recently unveiled woolly mice, a significant scientific milestone that indicates progress in their ambitious goal of reviving the woolly mammoth. This achievement, while showcasing the skill of gene editing, is considered a 'validation step' in the larger de-extinction project, according to CEO Ben Lamm. Investor Joe Manganiello remarked on the potential of the knowledge gained from this endeavor, hinting at possible applications in disease eradication. The undertaking may also address issues of generational trauma in biology, driven by personal motivations.
What many people misunderstood, Lamm said, was that successfully creating woolly mice was a "validation step" rather than a "first step" in the woolly mammoth de-extinction process.
The woolly mice have bigger implications for the Dallas-based company, even beyond its de-extinction and species preservation pipeline of projects.
Collection
[
|
...
]